Dr. Reddy's Laboratories Limited annual operating income for fiscal 2026 was $50.1 billion, a decrease of 30.4% from $72.0 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Operating Income (EBIT) | $50.1B | $72.0B | $65.3B | $59.1B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Operating Income (EBIT) | $829M | $14.3B | $17.9B | $16.8B | $16.2B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RDY metrics: Revenue · Gross Profit · Net Income · EPS · Free Cash Flow
All RDY financial statements → Interactive RDY charts →
About TickerBase · Data methodology & sources